Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →

All 40Congress 1Executive branch 0Insiders 39
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

HALO · sells only · $50K+ · 40 trades

Trades
40
Buys 0 · Sells 40
People
5
Stocks
1
Disclosed value
$23.6M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$248Kdisclosed Oct 8 · filed 2 days after the trade
  2. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$102Kdisclosed Oct 8 · filed 1 day after the trade
  3. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$337Kdisclosed Oct 8 · filed the same day
  4. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.2Mdisclosed Oct 8 · filed 1 day after the trade
  5. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.1Mdisclosed Oct 8 · filed 2 days after the trade
  6. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$955Kdisclosed Oct 8 · filed 1 day after the trade
  7. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$520Kdisclosed Oct 8 · filed the same day
  8. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.3Mdisclosed Oct 8 · filed the same day
  9. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$197Kdisclosed Oct 8 · filed 2 days after the trade
  10. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$656Kdisclosed Oct 8 · filed 2 days after the trade
  11. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$78.2Kdisclosed Oct 2 · filed 1 day after the trade
  12. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$358Kdisclosed Oct 2 · filed 1 day after the trade
  13. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$121Kdisclosed Oct 2 · filed 1 day after the trade
  14. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$961Kdisclosed Sep 17 · filed 1 day after the trade
  15. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$320Kdisclosed Sep 17 · filed 1 day after the trade
  16. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$436Kdisclosed Sep 17 · filed 1 day after the trade
  17. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$329Kdisclosed Sep 17 · filed 1 day after the trade
  18. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$485Kdisclosed Sep 11 · filed the same day
  19. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.4Mdisclosed Sep 11 · filed 2 days after the trade
  20. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$582Kdisclosed Sep 11 · filed 1 day after the trade
  21. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.6Mdisclosed Sep 11 · filed 1 day after the trade
  22. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$711Kdisclosed Sep 11 · filed 2 days after the trade
  23. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.7Mdisclosed Sep 11 · filed the same day
  24. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$89.1Kdisclosed Aug 19 · filed 2 days after the trade
  25. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1Mdisclosed Aug 19 · filed the same day